Ropes & Gray Advises Arsenal Capital Partners on £178 million Proposed Acquisition of Cello Health
Ropes & Gray has advised Arsenal Capital Partners – a US headquartered private equity firm with a strong track record in the life sciences market – on the proposed acquisition by its portfolio company Value Demonstration Holdings LLC of Cello Health plc, an AIM-listed global healthcare-focused advisory group. This transaction marks the latest in a number of private equity transactions Ropes & Gray has acted on in recent weeks in the life science and healthcare space.
Subject to certain regulatory approvals, the transaction will be effected by means of a scheme of arrangement and is expected to complete in August 2020.
Arsenal Capital Partners has a strong track-record of building market-leading companies in the life sciences and pharmaceutical services sector, and their portfolio company Value Demonstration Holdings LLC will work with Cello’s management towards their mission to improve patient health by accelerating and optimising patient access to medical innovations, especially those that have a transformative impact on people’s lives.
The Ropes & Gray team included private equity associate Victoria Srivastava (London), alongside tax partners David Saltzman (Boston) and Brenda Coleman (London).